Prosecution Insights
Prosecution Insights
Tech Center 3700 • Art Units: 3783 3791
This examiner grants 52% of resolved cases
Evelyn Grace Park is an examiner in Tech Center 3700 and Art Unit 3783, with 89 resolved cases. Her allowance rate of 51.7% indicates a balanced probability of success for patent applicants. This 51.7% rate suggests that about half of the applications result in a grant. The 89 resolved cases provide a representative sample of the outcomes in this art unit.
The median days to allowance is 1338, which represents a lengthy prosecution period. This 1338-day figure indicates that reaching a successful outcome can take over three years. For applicants, the 1338 days to allowance is a critical metric for long-term planning and resource allocation. This 1338-day duration is a defining feature of the prosecution experience in Tech Center 3700 under her review.
The interview lift of 39.2% is quite high, suggesting that interviews are a very powerful tool for securing an allowance. This 39.2% lift indicates that applications are much more likely to be allowed following an interview with the examiner. Given the 51.7% base allowance rate, the 39.2% lift is a critical factor for practitioners to consider. Utilizing the 39.2% lift could be the most effective strategy for successfully navigating the 89 resolved cases in Art Unit 3783.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17336188 | SYSTEMS AND METHODS FOR HYPERTENSION MONITORING | Non-Final OA | Apple Inc. |
| 17642600 | SYSTEMS AND METHODS FOR CONTINUOUS CARE | Final Rejection | ResMed Pty Ltd |
| 18327285 | OPERATION APPARATUS AND OPERATION ESTIMATION METHOD | Non-Final OA | Murata Manufacturing Co., Ltd. |
| 18701994 | System and Method for Analyzing Physiologic Signals | Final Rejection | BIOTRONIK SE & Co. KG |
| 18470633 | SYSTEMS AND METHODS FOR DETECTING PRESENCE OF EXCIPIENT OF INSULIN | Final Rejection | Medtronic MiniMed, Inc. |
| 18930109 | AMBIENT ABILITY ASSESSMENT AND CARE MANAGEMENT | Non-Final OA | Welch Allyn, Inc. |
| 18009384 | HYDRATION SENSOR FOR MONITORING AND DIAGNOSIS OF SKIN DISEASES IN ANY ENVIRONMENT AND APPLICATION OF SAME | Final Rejection | NORTHWESTERN UNIVERSITY |
| 18832365 | TECHNIQUES FOR IMPROVING EFFICIENCY OF DETECTION, COMMUNICATION, AND SECONDARY EVALUATION OF HEALTH EVENTS | Non-Final OA | Medtronic, Inc. |
| 18362458 | SYSTEM AND METHOD FOR ALIGNMENT OF A HANDHELD DEVICE WITH RESPECT TO AN EYE IMPLANT | Non-Final OA | Verily Life Sciences LLC |
| 19273853 | HEALTH MONITORING SYSTEM FOR LIMITING THE SPREAD OF AN INFECTION | Non-Final OA | Masimo Corporation |
| 18773701 | WEARABLE OPTICAL E-TATTOO FOR ARTERIAL AND VENOUS BLOOD OXYGENATION MONITORING | Non-Final OA | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM |
| 18956179 | BIOLOGICAL INFORMATION MEASUREMENT DEVICE | Non-Final OA | OMRON HEALTHCARE Co., Ltd. |
| 19109022 | METHODS AND SYSTEMS FOR PREDICTING HEALTH RISKS | Non-Final OA | The United States Government as Represented by the Department of Veterans Affairs |
| 17791451 | SYSTEMS AND METHODS INCLUDING EAR-WORN DEVICES FOR VESTIBULAR REHABILITATION EXERCISES | Final Rejection | Starkey Laboratories, Inc. |
| 18681448 | APPLICATOR FOR TRANSCUTANEOUS SENSOR, AND APPLICATOR ASSEMBLY | Non-Final OA | I-SENS, INC. |
| 18575315 | APPLICATOR FOR TRANSCUTANEOUS SENSOR, AND APPLICATOR ASSEMBLY | Final Rejection | I-SENS, INC. |
| 18575260 | APPLICATOR FOR TRANSCUTANEOUS SENSOR AND APPLICATOR ASSEMBLY | Final Rejection | I-SENS, INC. |
| 17913066 | COGNITIVE IMPAIRMENT DIAGNOSTIC DEVICE AND COGNITIVE IMPAIRMENT DIAGNOSTIC PROGRAM | Final Rejection | OSAKA UNIVERSITY |
| 18854965 | Non-Invasive Blood Glucose Prediction by Deduction Learning System | Non-Final OA | Academia Sinica |
| 18078067 | WEARABLE INFECTION MONITOR | Non-Final OA | Whoop, Inc. |
| 18371847 | APPARATUS FOR AUTOMATED PAIN TESTING IN RODENTS | Final Rejection | THE HOSPITAL FOR SICK CHILDREN |
| 17533479 | METHOD FOR DETERMINING THE METABOLIC PARAMETERS OF A SUBJECT | Non-Final OA | UNIVERSITE DE PARIS-SACLAY |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy